Financial results - CABINET NEUROLOGIE DR. BOTEZAT SRL

Financial Summary - Cabinet Neurologie Dr. Botezat Srl
Unique identification code: 35602149
Registration number: J2016000258165
Nace: 8622
Sales - Ron
97.787
Net Profit - Ron
79.462
Employees
1
Open Account
Company Cabinet Neurologie Dr. Botezat Srl with Fiscal Code 35602149 recorded a turnover of 2024 of 97.787, with a net profit of 79.462 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Cabinet Neurologie Dr. Botezat Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 11.577 16.722 24.038 31.510 37.786 55.550 78.351 86.534 97.787
Total Income - EUR - 11.577 16.722 24.038 31.510 37.786 55.550 78.351 86.534 97.787
Total Expenses - EUR - 560 645 1.006 620 219 868 277 8.916 15.831
Gross Profit/Loss - EUR - 11.017 16.076 23.031 30.890 37.568 54.682 78.074 77.618 81.956
Net Profit/Loss - EUR - 10.670 15.575 22.310 29.945 36.519 53.016 75.724 76.752 79.462
Employees - 0 0 0 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 13.6%, from 86.534 euro in the year 2023, to 97.787 euro in 2024. The Net Profit increased by 3.139 euro, from 76.752 euro in 2023, to 79.462 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Cabinet Neurologie Dr. Botezat Srl

Rating financiar

Financial Rating -
CABINET NEUROLOGIE DR. BOTEZAT...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Cabinet Neurologie Dr. Botezat...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cabinet Neurologie Dr. Botezat...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Cabinet Neurologie Dr. Botezat...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cabinet Neurologie Dr. Botezat Srl - CUI 35602149

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 80 43 2 0 1.835 1.121 1.125 0 1.101
Current Assets - 10.763 15.726 22.567 30.279 44.117 52.455 125.456 79.250 80.415
Inventories - 0 0 0 0 0 0 0 0 0
Receivables - 0 0 0 20.838 0 0 54.791 46.911 53.181
Cash - 10.763 15.726 22.567 9.441 44.117 52.455 70.665 32.339 27.234
Shareholders Funds - 10.714 15.619 22.353 29.987 36.560 53.056 75.764 76.793 79.520
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 129 151 215 292 9.391 520 50.816 2.457 1.997
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 80.415 euro in 2024 which includes Inventories of 0 euro, Receivables of 53.181 euro and cash availability of 27.234 euro.
The company's Equity was valued at 79.520 euro, while total Liabilities amounted to 1.997 euro. Equity increased by 3.156 euro, from 76.793 euro in 2023, to 79.520 in 2024.

Risk Reports Prices

Reviews - Cabinet Neurologie Dr. Botezat Srl

Comments - Cabinet Neurologie Dr. Botezat Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.